Skip to content
Hemodynamic Simulator
SharePoint
Data Management Platform
HometransQST
  • Home
  • Project
    • Objectives
    • Project Structure
    • Governance Structure
    • General Information
  • Consortium
    • Partners
    • Advisory Boards
  • News
    • Latest News
    • Newsletters
    • Meet the Team
  • Publications
    • Articles
    • Deliverables
  • Results
  • Contact us

Article 23 Dysregulated mesenchymal PDGFR-β drives kidney fibrosis

Articles

  • 29.09.202028.11.2022
  • Dysregulated mesenchymal PDGFR-β drives kidney fibrosis. Buhl E, Djudjaj S, Klinkhammer B, Ermert K, Puelles V, Lindenmeyer M, Cohen C, He C, Borkham-Kamphorst E, Weiskirchen R, Denecke B, Trairatphisan P, Saez-Rodriguez J, Huber T, Olson L, Floege J, Boor P. EMBO Molecular Medicine. 2020. 12:e11021. Partner involved: UKHD

    Post navigation

    Previous
    Next

    Subscribe to our newsletter

    Latest news

    Crown Bioscience Joins TransQST
    17.02.2022
    TransQST present at the University of Liverpool´s Research Integrity Annual Lecture
    23.12.2021
    TransQST 8th General Assembly Meeting
    22.11.2021
    OcellO is Acquired by CrownBio to Complement a Strong Product Portfolio
    01.07.2021

    Acknowledgement

    This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116030. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

    Disclaimer
    About IMI

    ©2017 TransQST | Translational Quantitative Systems Toxicology

    Scroll to top